Company Filing History:
1 out of 16,087 
1 out of 8,693 
Years Active: 2009-2012
Title: Sanjai Kumar: Innovator in Vaccine Development
Introduction
Sanjai Kumar is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of vaccine development, particularly in the area of malaria research. With a total of 2 patents, his work has implications for both therapeutic and diagnostic applications.
Latest Patents
One of his latest patents focuses on the expression, purification, and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide. This application describes the expression and purification of a recombinant (3D7) LSA-NRC polypeptide. The method outlined in this patent produces a highly purified polypeptide that is useful as a vaccine and as a diagnostic reagent.
Career Highlights
Throughout his career, Sanjai Kumar has worked with various organizations, including the United States Government as represented by the Secretary of the Navy and the Secretary of the Army. His expertise in recombinant polypeptide technology has positioned him as a key player in the development of innovative solutions for infectious diseases.
Collaborations
Sanjai has collaborated with notable colleagues such as David E. Lanar and Collette J. Hillier. Their combined efforts have contributed to advancements in vaccine research and development.
Conclusion
Sanjai Kumar's work exemplifies the impact of innovative research in the field of vaccine development. His contributions continue to pave the way for advancements in medical science and public health.